Sign Up
Stories
Biotech Collaboration for Innovative Solutions
Share
4DMT Presents Positive Interim Data
Advancements in Gene Editing and Cancer ...
Biopharma Breakthroughs and Safety Advan...
Biotech Market Surge: Revenue Forecast
Concr: Astrophysics-Driven Healthtech
EMA Backs Ocugen's Gene Therapy
Overview
API
Modalis Therapeutics partners with Ginkgo Bioworks to leverage CRISPR technology for diverse industries.
Ask a question
How could this partnership influence the landscape of synthetic biology research and applications globally?
How might the integration of CRISPR technology impact the development of new therapies?
What specific breakthroughs can be expected in the fields of food, agriculture, and pharmaceuticals from this collaboration?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage